Cargando…
Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases
Indirubin is the active component of Danggui Longhui Wan, a traditional Chinese medicine formulation. The encouraging clinical results from the 1980s obtained in chronic myelocytic leukemia patients treated with indirubin stimulated numerous studies on this compound. These investigations explored th...
Autores principales: | Blažević, Tina, Heiss, Elke H., Atanasov, Atanas G., Breuss, Johannes M., Dirsch, Verena M., Uhrin, Pavel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589628/ https://www.ncbi.nlm.nih.gov/pubmed/26457112 http://dx.doi.org/10.1155/2015/654098 |
Ejemplares similares
-
Indirubin-3′-monoxime exerts a dual mode of inhibition towards leukotriene-mediated vascular smooth muscle cell migration
por: Blažević, Tina, et al.
Publicado: (2014) -
Increased aerobic glycolysis is important for the motility of activated VSMC and inhibited by indirubin-3′-monoxime
por: Heiss, Elke H., et al.
Publicado: (2016) -
An Indirubin Derivative, Indirubin-3′-Monoxime Suppresses Oral Cancer Tumorigenesis through the Downregulation of Survivin
por: Lo, Wan-Yu, et al.
Publicado: (2013) -
Indirubin derivative E804 inhibits angiogenesis
por: Shin, Eun-Kyung, et al.
Publicado: (2012) -
Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents
por: Efstathiou, Antonia, et al.
Publicado: (2018)